Ryan Fukushima Sells 20,000 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) COO Ryan Fukushima sold 20,000 shares of Tempus AI stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $51.15, for a total transaction of $1,023,000.00. Following the sale, the chief operating officer now owns 924,460 shares in the company, valued at approximately $47,286,129. This trade represents a 2.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Ryan Fukushima also recently made the following trade(s):

• On Wednesday, February 19th, Ryan Fukushima sold 2,868 shares of Tempus AI stock. The shares were sold at an average price of $81.87, for a total transaction of $234,803.16.
• On Tuesday, February 4th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $62.50, for a total transaction of $1,250,000.00.
• On Tuesday, January 7th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The stock was sold at an average price of $39.61, for a total transaction of $792,200.00.
• On Monday, December 16th, Ryan Fukushima sold 3,500 shares of Tempus AI stock. The shares were sold at an average price of $40.23, for a total transaction of $140,805.00.
• On Wednesday, December 11th, Ryan Fukushima sold 120,000 shares of Tempus AI stock. The stock was sold at an average price of $42.51, for a total transaction of $5,101,200.00.

Tempus AI Stock Performance

Shares of NASDAQ TEM traded up $0.24 during mid-day trading on Friday, reaching $49.10. 9,329,504 shares of the company's stock were exchanged, compared to its average volume of 4,780,820. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm has a 50-day moving average price of $54.02 and a two-hundred day moving average price of $52.54.

Remove Ads

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. ARK Investment Management LLC grew its holdings in shares of Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock worth $134,604,000 after purchasing an additional 1,855,459 shares during the last quarter. Sigma Planning Corp bought a new stake in Tempus AI in the third quarter valued at $1,323,000. GSA Capital Partners LLP bought a new stake in Tempus AI in the third quarter valued at $306,000. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock valued at $68,922,000 after acquiring an additional 1,145,698 shares in the last quarter. Finally, First Horizon Advisors Inc. bought a new stake in shares of Tempus AI during the 3rd quarter valued at $30,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TEM has been the topic of several research reports. Morgan Stanley upped their price target on shares of Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a research note on Thursday. William Blair reiterated a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. TD Cowen restated a "buy" rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Bank of America raised their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a report on Monday, March 3rd. Finally, Loop Capital lowered their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday, January 14th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $61.18.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.